
Popular restaurant unknowingly drugs customers by serving them marijuana pizza, CDC report claims
Famous Yeti's Pizza in Stoughton, Wisconsin, unintentionally served pizzas contaminated with THC, the psychoactive compound in marijuana, between October 22 and October 24, 2024.
In a new CDC report, EMS workers reportedly notified the public health department that they transported seven people to the hospital with THC intoxication-related symptoms, including dizziness, anxiety, paranoia and hallucinations over the course of the two days.
All of the patients reported eating at Famous Yeti's, and one patient said they felt similar to when they took a THC edible.
He and the other patients, ranging from ages 1 to 91, later tested positive for the drug, the public health department reported.
An investigation determined that on October 22, the restaurant had run out of cooking oil and used oil from a shared cooperative kitchen located in the same building.
One of the vendors who used the kitchen made edible products using that cooking oil, which contained hemp-derived THC.
Hemp-derived THC can cause a range of side effects including intoxication, altered senses, impaired thinking and coordination, anxiety, and in some cases, more severe reactions like hallucinations or paranoia.
In addition to the seven people taken to hospital, 78 others who dined at the restaurant revealed in a health questionnaire that they had at least one symptom of THC intoxication within five hours after dining there.
Some of the complaints claimed they suffered from dizziness, sleepiness, anxiety, increased heart rate, nausea, paranoia, panic attack, increased blood pressure, vomiting, and hallucinations.
All 85 people who were identified made full recoveries without any complications.
The only label warning that the borrowed cooking oil contained THC was on the cap, which the operator reportedly saw, according to the health department.
Famous Yeti's later addressed the issue by posting a public notice on its Facebook page.
Its owner Cale Ryan wrote at the time: 'In the past few days, we at Famous Yeti's Pizza made a horrendous mistake and in doing so, compromised the trust we have spent 12 and a half years building with this amazing town.
'We put people and families at risk and frightened and confused children and parents.
'This is incredibly serious to us and we can't imagine anything worse than betraying the faith that our customers have in us to provide a product made with [the] utmost care and without concern.
'We acted with carelessness in prepping dough and ended up tainting our product that we take so much pride in.'
Ryan went on to say that as the owner he took 'full responsibility for this oversight.'
He added: 'I am incredibly sorry that I allowed us to act this irresponsibly and ended up hurting the people who have made Yeti's the wonderful place it has been.
'All I can ask from here is your forgiveness and your faith that he will do everything within our power to earn that trust and love back.
Still, he said: 'If we lost your faith in us and we never get to serve you again, I completely understand.
'We made a tremendous error and know that we will always be here with an open ear and an open heart, and we will work furiously to earn this privilege to provide for your sometime again.'
A police investigation concluded that the provision of THC-contaminated food to customers was unintentional, and no criminal charges were pursued.
The restaurant reopened on October 26 after cleaning and sanitizing following standards in the Wisconsin Food Code.
More than six months on, the restaurant is still in business and it remains a popular local eatery.
Following the incident, the CDC warns restaurants that clear labeling and locked storage for ingredients containing THC is essential in ensuring customer safety.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
2 hours ago
- Daily Mail
Menopause made my hair fall out. Then I discovered a new hair-loss solution. This is the secret ALL midlife women need to know
For me, midlife has brought various indignities, as well as many joys. But standing over a sink to count the number of hairs that had come out in my brush one morning has to be among the more distressing aspects. For the record, it was 201. And why was I counting them? Because I'd searched 'how to tell if your hair is falling out' online – and according to Dr Google, anything over 100 strands was a cause for concern.


The Independent
3 hours ago
- The Independent
WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs
WeightWatchers was slower to adapt to the emergence of anti-obesity jabs than rivals, its boss has admitted, as the 62-year-old brand strives to catch up with rapidly evolving attitudes towards weight loss. Tara Comonte, chief executive of the US-based business, said it had a lot of work to do after going through a 'reset'. WeightWatchers recently announced it had emerged from bankruptcy after writing off a portion of the 1.15 billion US dollar (£860 million) debt on its balance sheet. It came as the business was competing with the emergence of GLP-1s – the scientific term for weight loss jabs, which work by reducing food cravings – and a new wave of apps and advice spreading on social media. Ms Comonte told the PA news agency that it 'wasn't as quick to medical weight loss solutions' as some other firms in the US, notably so-called 'telehealth' businesses that offer healthcare remotely. WeightWatchers, which runs some 20,000 workshops each month globally, is now 'at the beginning of the journey' towards forging a new place in the industry and meeting demand from current and future members, Ms Comonte said. 'This whole industry is going through somewhat of a reset and we have exciting work to do,' she told the PA news agency. 'This is a moment where, possibly more than ever before, people are talking about weight, and weight health… where people are seeking more education than ever before, and there are more voices than ever before.' Ms Comonte said the brand was known for 'trust and science' and it was important to harness that 'as there are more and more voices in the ecosystem'. WeightWatchers recently partnered with anti-obesity drugs provider CheqUp in the UK so patients taking the medication can access its 'companion' diet and lifestyle support app. It forms part of its efforts to muscle into the market by offering behavioural strategies and community-based support to people using or coming off the medication. 'There's no 'us and them' anymore,' Ms Comonte told PA, hitting back at weight loss jabs often being pitted as rivals to its model. Dr Kim Boyde, WeightWatchers' newly appointed chief medical officer, said not all its members will want or need weight loss medication – but stressed that it was 'imperative' the programme offers it to those that might benefit. Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects.


Reuters
4 hours ago
- Reuters
Roche to investigate whether new drug can delay or prevent Alzheimer's disease
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.